Skip to main content

BEL invites potential investors in Middle East

BEL invites potential investors in Middle East

 Under the auspices of the Department of Investment and Public Asset Management (DIPAM) and the Ministry of Defence (MoD), Navratna defense PSU Bharat Electronics Limited (BEL) will take part in the Investors Outreach Program in the Middle East (Dubai & Abu Dhabi) from September 12 to 15, 2022. Potential investors in Dubai and Abu Dhabi have been hearing presentations from Dinesh Kumar Batra, CMD, Director (Finance), and CFO, on why they ought to invest in BEL.

Batra informed investors that BEL is a technology-driven company that produces essential defense systems, products, and solutions, has a world-class manufacturing infrastructure, and has a strong order book and consistent profit growth over the past three years. BEL has also participated in a number of Government of India indigenization initiatives, including Atmanirbhar Bharat and Make in India.

He emphasized that BEL has an ICRA Credit Rating of AAA (Stable - Long Term) and A1+ (Short Term); consistent revenue and profitability performance; a strong balance sheet; zero debt; positive cash flow; and annual dividend payments that are substantial for shareholders. BEL announced bonus shares with a 2:1 ratio in August 2022. According to Batra, BEL's market valuation climbed from USD 6,050 million to USD 10,100 million in the previous year.

BEL has expanded its business to include arms and ammunition, missiles and seeker technology, network and cyber security, unmanned systems, medical electronics, solutions for railway, metro, and airports, space electronics and systems, infrastructure for charging electric vehicles, alternative energy sources, secure communication technologies, and software.

This Investors Outreach Program aims to educate potential institutional and high-value investors about the general growth story of India and the allure of Defense PSUs. The numerous government initiatives to support the defense industry have generated vitality and assisted BEL in expanding its services to worldwide markets in addition to meeting domestic demand.


Comments

Popular posts from this blog

Netanyahu’s Shocking Gaza Plan: ‘We Will Take Control of ALL of Gaza’ — But At What Cost?

  As Israeli forces intensify their offensive, Netanyahu vows total control of Gaza — but the humanitarian crisis is reaching a breaking point. Will the world stand by and watch? Israeli Prime Minister Benjamin Netanyahu has declared that Israel will “take control of all” of the Gaza Strip, signaling an unprecedented escalation in the ongoing conflict. In a video posted to Telegram, Netanyahu emphasized that military operations are advancing rapidly, with no intention of backing down. “The fighting is intense, and we are making progress,” he said, framing the offensive as necessary for Israel’s long-term security. But as international pressure mounts, his government is walking a tightrope between military dominance and global condemnation. The Israeli military has ordered mass evacuations in southern Gaza, warning residents of Khan Yunis and surrounding areas to flee immediately ahead of a devastating assault. Arabic-language spokesman Avichay Adraee described the coming attack as ...

Israel issues latest forced evacuation order in areas in Khan Younis

  The Israeli army’s Arabic-language spokesperson, Avichay Adraee, has issued the latest forced evacuation order for civilians living in nine areas in Khan Younis, southern Gaza. Adraee said that the army was expanding its operation and “intensifying sudden and concentrated firepower”. The spokesperson called on residents to evacuate westward. So-called Israeli safe zones, including Al-Mawasi in Khan Younis, are routinely attacked despite the army forcing Palestinians to move to those areas.

UAE initiates extensive CAR T-cell treatment in the region

The United Arab Emirates has transformed the medical structure of the region as it slowly moves towards attaining leadership in medical treatments and complex procedures. It has stepped up on the list with a pioneering treatment led by Abu Dhabi. The capital has witnessed a revolutionary process that focuses on the safety and efficacy of using the CAR T-Cell treatment module especially for hematologic or blood cancers such as lymphoma, myeloma, and certain types of leukemia. This is an exemplary step in the context of the region as it is the first of its kind treatment here.  On Saturday, the Emirati nation began its experiment to locally manufacture CAR T-Cell treatment at Abu Dhabi Stem Cells Center. The T-Cells will be locally reprogrammed and tested for their effectiveness so that they get better results when it comes to treating cancer.   The unit for the stem cell treatment ADSCC was founded in 2019 and since then it has grown threefold when it comes to experimenting wit...